HRP20191368T1 - Alkil-amid supstituirani piridil spojevi korisni kao modulatori il-12, il-23 i/ili ifnalfa odgovora - Google Patents
Alkil-amid supstituirani piridil spojevi korisni kao modulatori il-12, il-23 i/ili ifnalfa odgovoraInfo
- Publication number
- HRP20191368T1 HRP20191368T1 HRP20191368T HRP20191368T1 HR P20191368 T1 HRP20191368 T1 HR P20191368T1 HR P20191368 T HRP20191368 T HR P20191368T HR P20191368 T1 HRP20191368 T1 HR P20191368T1
- Authority
- HR
- Croatia
- Prior art keywords
- ifnalpha
- modulators
- responses
- amide
- alkyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW102140574A TWI582077B (zh) | 2013-11-07 | 2013-11-07 | 作爲IL-12、IL-23及/或IFNα反應調節劑之經烷基-醯胺取代之吡啶化合物 |
ARP130104090A AR094537A1 (es) | 2013-11-07 | 2013-11-07 | COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O IFNa |
VE140013 | 2013-11-11 | ||
PCT/US2014/011769 WO2015069310A1 (en) | 2013-11-07 | 2014-01-16 | Alkyl-amide-substituted pyridyl compounds useful as modulators of il-12, il-23 and/or ifnalpha responses |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20191368T1 true HRP20191368T1 (hr) | 2019-11-29 |
Family
ID=56241743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20191368 HRP20191368T1 (hr) | 2013-11-07 | 2019-07-30 | Alkil-amid supstituirani piridil spojevi korisni kao modulatori il-12, il-23 i/ili ifnalfa odgovora |
Country Status (31)
Country | Link |
---|---|
US (2) | US9663467B2 (hr) |
EP (2) | EP3590926A1 (hr) |
JP (1) | JP6312823B2 (hr) |
KR (1) | KR102186633B1 (hr) |
CN (1) | CN106660960B (hr) |
AR (1) | AR094537A1 (hr) |
AU (1) | AU2014347275B2 (hr) |
CA (1) | CA2930060C (hr) |
CL (1) | CL2016001101A1 (hr) |
CY (1) | CY1122065T1 (hr) |
DK (1) | DK3066078T3 (hr) |
EA (1) | EA033272B1 (hr) |
ES (1) | ES2738826T3 (hr) |
HK (1) | HK1226400A1 (hr) |
HR (1) | HRP20191368T1 (hr) |
HU (1) | HUE046052T2 (hr) |
IL (1) | IL245448B (hr) |
LT (1) | LT3066078T (hr) |
MA (1) | MA39001A1 (hr) |
MX (1) | MX369394B (hr) |
MY (1) | MY174453A (hr) |
NZ (1) | NZ720710A (hr) |
PE (1) | PE20160961A1 (hr) |
PH (1) | PH12016500779A1 (hr) |
PL (1) | PL3066078T3 (hr) |
PT (1) | PT3066078T (hr) |
RS (1) | RS59125B1 (hr) |
SI (1) | SI3066078T1 (hr) |
TN (1) | TN2016000153A1 (hr) |
TW (1) | TWI582077B (hr) |
WO (1) | WO2015069310A1 (hr) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI3495358T1 (sl) | 2012-11-08 | 2022-06-30 | Bristol-Myers Squibb Company | z amidi substituirane heterociklične spojine, uporabne kot modulatorji IL-12, IL-23 in/ali IFN alfa odzivov |
CN104903301B (zh) | 2012-11-08 | 2017-08-29 | 百时美施贵宝公司 | 可用于调节IL‑12、IL‑23和/或IFNα的烷基酰胺取代的嘧啶化合物 |
CN105473550B (zh) | 2013-07-01 | 2019-02-15 | 百时美施贵宝公司 | Ido抑制剂 |
UA119050C2 (uk) | 2013-11-11 | 2019-04-25 | Ґілеад Саєнсиз, Інк. | ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ |
ES2702126T3 (es) | 2013-12-10 | 2019-02-27 | Bristol Myers Squibb Co | Compuestos de imidazopiridazina útiles como moduladores de respuestas a IL-12, IL-23 y/o IFN alfa |
JP6843775B2 (ja) | 2015-06-24 | 2021-03-17 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | ヘテロアリール置換のアミノピリジン化合物 |
ES2822956T3 (es) | 2015-06-24 | 2021-05-05 | Bristol Myers Squibb Co | Compuestos de aminopiridina sustituidos con heteroarilo |
ES2930198T3 (es) | 2016-10-14 | 2022-12-07 | Nimbus Lakshmi Inc | Inhibidores de TYK2 y usos de los mismos |
CN110114357B (zh) | 2016-10-28 | 2022-05-31 | 百时美施贵宝公司 | 可用作IL-12、IL-23和/或IFNα反应的调节剂的杂双环化合物 |
KR102611856B1 (ko) * | 2016-11-17 | 2023-12-07 | 브리스톨-마이어스 스큅 컴퍼니 | Il-12, il-23 및/또는 ifn-알파의 이미다조피리다진 조정제 |
EP3555111B1 (en) * | 2016-12-13 | 2022-01-26 | Bristol-Myers Squibb Company | Phosphine oxide alkyl amide substituted heteroaryl compounds as modulators of il-12, il-23, and/or ifn alpha responses |
IL269586B (en) | 2017-03-30 | 2022-08-01 | Bristol Myers Squibb Co | Process for preparing 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-h1-1, 2, 4- triazol-3-yl)phenyl)amino)-n-(methyl-3d)pyridazine -3-carboxamide |
SI3621960T1 (sl) | 2017-05-11 | 2021-11-30 | Bristol-Myers Squibb Company | Tienopiridini in benzotiofeni uporabni kot irak4 inhibitorji |
MX2020005210A (es) | 2017-11-21 | 2020-08-20 | Bristol Myers Squibb Co | Compuestos de heteroarilo sustituidos con alquilamida de piridinsulfona. |
TW201940483A (zh) | 2018-03-12 | 2019-10-16 | 美商艾伯維有限公司 | 酪胺酸激酶2介導的傳訊之抑制劑 |
US11572360B2 (en) * | 2018-08-16 | 2023-02-07 | Innate Tumor Immunity, Inc. | Substituted 4-amino-1H-imidazo[4,5-c]quinoline compounds and improved methods for their preparation |
CA3117200A1 (en) | 2018-10-22 | 2020-04-30 | Esker Therapeutics, Inc. | Tyk2 inhibitors and uses thereof |
WO2020092196A1 (en) * | 2018-10-30 | 2020-05-07 | Bristol-Myers Squibb Company | Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of il-12, il-23 and/or ifn-alpha |
WO2020156311A1 (zh) * | 2019-01-28 | 2020-08-06 | 江苏豪森药业集团有限公司 | 一种哒嗪类衍生物抑制剂、其制备方法和应用 |
CN113365982A (zh) * | 2019-01-30 | 2021-09-07 | 百时美施贵宝公司 | 酰胺二取代的吡啶或哒嗪化合物 |
KR20220002488A (ko) | 2019-04-30 | 2022-01-06 | 셀진 코포레이션 | 아프레밀라스트 및 tyk2 억제제를 포함하는 조합 요법 |
US20220204495A1 (en) * | 2019-05-03 | 2022-06-30 | Valo Health, Inc. | Inhibiting trabid |
JP2022541772A (ja) | 2019-07-16 | 2022-09-27 | ブリストル-マイヤーズ スクイブ カンパニー | インターロイキンの調節におけるプロドラッグ |
MX2022011297A (es) | 2020-03-11 | 2022-10-07 | Beijing Innocare Pharma Tech Co Ltd | Compuestos heterociclicos para inhibir las actividades de tyk2. |
WO2021204626A1 (en) * | 2020-04-06 | 2021-10-14 | Almirall, S.A. | Aryl and heteroaryl-carboxamide substituted heteroaryl compounds as tyk2 inhibitors |
CA3174845A1 (en) * | 2020-04-14 | 2021-10-21 | Craig Alan Coburn | Substituted pyridines for the treatment of inflammatory diseases |
CN113563309A (zh) * | 2020-04-28 | 2021-10-29 | 浙江海正药业股份有限公司 | 吡啶类衍生物及其制备方法和用途 |
WO2021222153A1 (en) * | 2020-04-28 | 2021-11-04 | Bristol-Myers Squibb Company | Substituted n-(methyl-d3)pyridazine-3-carboxamide or n-(methyl-d3)-nicotinamide compounds as il-12, il-23 and/or ifnalpha modulators |
WO2021237121A1 (en) * | 2020-05-21 | 2021-11-25 | Gossamer Bio Services, Inc. | Substituted pyridines |
EP3944859A1 (en) | 2020-07-30 | 2022-02-02 | Assistance Publique Hôpitaux de Paris | Method for treating immune toxicities induced by immune checkpoint inhibitors |
WO2022105771A1 (zh) * | 2020-11-17 | 2022-05-27 | 江苏恒瑞医药股份有限公司 | 含氮杂环类衍生物、其制备方法及其在医药上的应用 |
CN112625030A (zh) * | 2020-12-25 | 2021-04-09 | 杭州澳赛诺生物科技有限公司 | 一种一锅法合成n-保护3-溴代吡唑的合成方法 |
TW202233600A (zh) * | 2021-02-06 | 2022-09-01 | 大陸商正大天晴藥業集團股份有限公司 | 含聯環的tyk2抑制劑化合物、藥物組合物及其用途 |
WO2022193499A1 (en) * | 2021-03-16 | 2022-09-22 | Anrui Biomedical Technology (Guangzhou) Co., Ltd. | Amino heteroaryl compounds and compositions |
WO2022233286A1 (zh) * | 2021-05-04 | 2022-11-10 | 上海喆邺生物科技有限公司 | 一类含氮杂环吡啶类化合物 |
WO2022253335A1 (zh) * | 2021-06-02 | 2022-12-08 | 南京明德新药研发有限公司 | 含磺酰基的芳基类化合物及其应用 |
CA3232812A1 (en) | 2021-09-23 | 2023-03-30 | Ian MacQuarie CATLETT | Methods of treating hair-loss disorders with tyk2 inhibitors |
CA3236262A1 (en) | 2021-10-25 | 2023-05-04 | Isaac Marx | Tyk2 degraders and uses thereof |
TW202339749A (zh) * | 2021-12-16 | 2023-10-16 | 大陸商凌科藥業有限公司 | Tyk2抑制劑及其組合物和方法 |
WO2023108536A1 (en) * | 2021-12-16 | 2023-06-22 | Lynk Pharmaceuticals Co. Ltd. | Tyk2 inhibitors and compositions and methods thereof |
WO2023213308A1 (zh) * | 2022-05-05 | 2023-11-09 | 苏州隆博泰药业有限公司 | 酰胺取代的杂环化合物及其医药用途 |
WO2024020221A1 (en) | 2022-07-21 | 2024-01-25 | Arvinas Operations, Inc. | Modulators of tyk2 proteolysis and associated methods of use |
WO2024042361A1 (en) * | 2022-08-24 | 2024-02-29 | Sudo Biosciences Limited | Tyk2 inhibitors and uses thereof |
WO2024042363A1 (en) * | 2022-08-24 | 2024-02-29 | Sudo Biosciences Limited | Tyk2 inhibitors and uses thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7176214B2 (en) | 2003-05-21 | 2007-02-13 | Bristol-Myers Squibb Company | Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
US20050049276A1 (en) | 2003-07-23 | 2005-03-03 | Warner-Lambert Company, Llc | Imidazopyridines and triazolopyridines |
TW201040162A (en) * | 2009-05-06 | 2010-11-16 | Portola Pharm Inc | Inhibitors of JAK |
AR077033A1 (es) * | 2009-06-11 | 2011-07-27 | Hoffmann La Roche | Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas |
WO2013054351A1 (en) * | 2011-08-08 | 2013-04-18 | Cadila Healthcare Limited | Heterocyclic compounds |
JP5957537B2 (ja) | 2011-12-21 | 2016-07-27 | ビオタ ヨーロッパ リミテッドBiota Europe Ltd | 複素環式ウレア化合物 |
JP2015500862A (ja) * | 2011-12-23 | 2015-01-08 | セルゾーム リミティッド | キナーゼ阻害剤としてのピリミジン−2,4−ジアミン誘導体 |
CN104903301B (zh) | 2012-11-08 | 2017-08-29 | 百时美施贵宝公司 | 可用于调节IL‑12、IL‑23和/或IFNα的烷基酰胺取代的嘧啶化合物 |
SI3495358T1 (sl) | 2012-11-08 | 2022-06-30 | Bristol-Myers Squibb Company | z amidi substituirane heterociklične spojine, uporabne kot modulatorji IL-12, IL-23 in/ali IFN alfa odzivov |
MX2015005272A (es) | 2012-11-08 | 2015-07-14 | Squibb Bristol Myers Co | Compuestos de piridilo sustituidos con alquilamida utiles como moduladores de las respuestas de interleucina 12 (il-12), interleucina 23 (il-23) y/o interferon alfa (ifnalfa). |
ES2702126T3 (es) | 2013-12-10 | 2019-02-27 | Bristol Myers Squibb Co | Compuestos de imidazopiridazina útiles como moduladores de respuestas a IL-12, IL-23 y/o IFN alfa |
-
2013
- 2013-11-07 TW TW102140574A patent/TWI582077B/zh active
- 2013-11-07 AR ARP130104090A patent/AR094537A1/es active IP Right Grant
-
2014
- 2014-01-16 CN CN201480072423.2A patent/CN106660960B/zh active Active
- 2014-01-16 KR KR1020167014612A patent/KR102186633B1/ko active IP Right Grant
- 2014-01-16 LT LTEP14702707.2T patent/LT3066078T/lt unknown
- 2014-01-16 MA MA39001A patent/MA39001A1/fr unknown
- 2014-01-16 ES ES14702707T patent/ES2738826T3/es active Active
- 2014-01-16 WO PCT/US2014/011769 patent/WO2015069310A1/en active Application Filing
- 2014-01-16 EA EA201690865A patent/EA033272B1/ru not_active IP Right Cessation
- 2014-01-16 PL PL14702707T patent/PL3066078T3/pl unknown
- 2014-01-16 CA CA2930060A patent/CA2930060C/en active Active
- 2014-01-16 US US15/034,915 patent/US9663467B2/en active Active
- 2014-01-16 HU HUE14702707A patent/HUE046052T2/hu unknown
- 2014-01-16 EP EP19173861.6A patent/EP3590926A1/en not_active Withdrawn
- 2014-01-16 DK DK14702707.2T patent/DK3066078T3/da active
- 2014-01-16 MX MX2016005853A patent/MX369394B/es active IP Right Grant
- 2014-01-16 SI SI201431231T patent/SI3066078T1/sl unknown
- 2014-01-16 JP JP2016528221A patent/JP6312823B2/ja active Active
- 2014-01-16 NZ NZ720710A patent/NZ720710A/en unknown
- 2014-01-16 PT PT14702707T patent/PT3066078T/pt unknown
- 2014-01-16 TN TN2016000153A patent/TN2016000153A1/en unknown
- 2014-01-16 AU AU2014347275A patent/AU2014347275B2/en active Active
- 2014-01-16 PE PE2016000603A patent/PE20160961A1/es unknown
- 2014-01-16 EP EP14702707.2A patent/EP3066078B1/en active Active
- 2014-01-16 RS RS20191041A patent/RS59125B1/sr unknown
- 2014-01-16 MY MYPI2016701601A patent/MY174453A/en unknown
-
2016
- 2016-04-27 PH PH12016500779A patent/PH12016500779A1/en unknown
- 2016-05-03 IL IL245448A patent/IL245448B/en active IP Right Grant
- 2016-05-06 CL CL2016001101A patent/CL2016001101A1/es unknown
- 2016-12-23 HK HK16114678A patent/HK1226400A1/zh unknown
-
2017
- 2017-04-06 US US15/480,787 patent/US9987266B2/en active Active
-
2019
- 2019-07-30 HR HRP20191368 patent/HRP20191368T1/hr unknown
- 2019-08-14 CY CY20191100878T patent/CY1122065T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20191368T1 (hr) | Alkil-amid supstituirani piridil spojevi korisni kao modulatori il-12, il-23 i/ili ifnalfa odgovora | |
HUS2300025I1 (hu) | Amidszubsztituált heterociklikus vegyületek mint IL-12, IL-23 és/vagy IFN-ALFA modulátorai | |
IL238554A0 (en) | Alkyl-amide substituted pyridyl compounds are useful as modulators of il12, il23, and/or ifnα responses | |
EP3065875A4 (en) | Bioprinter and methods of using same | |
EP3149151A4 (en) | Sample preparation devices and methods | |
HK1210398A1 (en) | Devices and methods facilitating sleeve gastrectomy and other procedures | |
GB2535964B (en) | Spectrophotometric sensors and methods using same | |
PL2988756T3 (pl) | Formulacja środka kontrastowego i powiązany sposób jego wytwarzania | |
GB201312318D0 (en) | Novel methods and compounds | |
EP2968380A4 (en) | Methods and devices for affecting nerve function | |
HUE040436T2 (hu) | Ciflufenamidot és spiroxamint tartalmazó hatóanyag-kombinációk | |
EP3073818A4 (en) | Cheese-making methods and apparatuses | |
EP3146869A4 (en) | Air-circulating mat | |
AU2014902782A0 (en) | Baby patting device | |
AU2013901167A0 (en) | Health Preservation |